News
Hosted on MSN2mon
Novo Insulin Pen Retreat Risks Drug Access to Kids with Diabetes ...Novo Nordisk, Eli Lilly & Co. and Sanofi dominate the market for insulin products worldwide, while the much-smaller Biocon is a key player in the copycat segment. The global insulin-pen market is ...
The agreement covers integrating DBL-4pen™, Diabeloop's self-learning algorithm for MDI therapy, with Novo Nordisk's connected and reusable insulin pens, NovoPen® 6 and NovoPen Echo® Plus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback